Technosphere Inhalation Powder
Sponsors
Mannkind Corporation
Conditions
Diabetes MellitusDiabetes Mellitus, Type 2Mild NephropathyModerate Nephropathy
Phase 1
Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
CompletedNCT00626249
Start: 2007-08-31End: 2008-10-31Updated: 2013-12-17
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
CompletedNCT00642538
Start: 2008-02-29End: 2008-09-30Updated: 2012-06-14